A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification
Clinical trial NCT02906917 · COMPLETED
Trial details
- NCT number
- NCT02906917
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-20
- Primary completion
- 2017-08-31
- Enrollment
- 532
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.